Cosentyx, Entresto again drive growth at Novartis. But what about the future of Zolgensma? | Fierce Pharma
Work Stride and Novartis honored for Most Valuable Collaboration - Johns Hopkins HealthyWorks
It Paid Doctors Kickbacks. Now, Novartis Will Pay a $678 Million Settlement. - The New York Times
Novartis in Society US Reports | Novartis United States of America
Canadian company AccessNow wins Novartis Innovation Prize for Assistive Tech - AccessNow
ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half | Fierce Biotech
Novartis 2019: Innovating for challenging healthcare issues – PharmaLive
Novartis Launches STEP Program™
Novartis in Society 2019 US Report
The Process of CAR-T Cell Therapy | Novartis
Novartis sharpens focus on vision-restoring gene therapy with $150M Vedere buyout | Fierce Biotech
Program Overview | Novartis United States of America
Novartis' Netflix moment? Big Pharma launches on-demand hub
Novartis - About the Novartis US Foundation and the TMCF Alliance | Thurgood Marshall College Fund
Novartis Sees Glimmer of Hope for Branaplam in Huntington's Disease | BioSpace
Novartis to Spin Off, List Sandoz Drugs Business - WSJ
Novartis to Sell Roche Stake for $20.7 Billion - WSJ
File:The Novartis 60-g total synthesis of (+)-discodermolide endgame.png - Wikimedia Commons
Novartis Launches STEP Program™
2019 Q4 and Full Year Results Presentation & Transcript | Novartis
Novartis pays $100M for Mallinckrodt's priority review voucher
Novartis Launches STEP Program™
The STEP Program™: Supporting Solutions from Patient Advocacy Organizations – Support Sight Foundation
Novartis Stock: Cheap, AA-Rated Pharma, It's Time To 'Buy' (NYSE:NVS) | Seeking Alpha
Novartis Launches STEP Program™
Novartis Suspended Top Scientists Before FDA Disclosure - Bloomberg
